Additionally, programmed death receptor-1/programmed cell death one ligand 1 (PD-1/PD-L1) checkpoint inhibitors are promising treatments in advanced HCC nowadays and in the future, which is also involved in immune evasion (Li et al., 2022; Hao et al., 2023). Here, CD274 is linked to hepatocellular carcinoma.